City
Epaper

South Korea's pharmaceutical, biotechnology exports surge 55 pc in H1

By IANS | Updated: June 29, 2024 11:50 IST

Seoul, June 29 South Korea's exports of pharmaceutical and biotechnologies surged from a year earlier in the first ...

Open in App

Seoul, June 29 South Korea's exports of pharmaceutical and biotechnologies surged from a year earlier in the first half of the year, data showed on Saturday.

In the first six months of the year, the country exported 4.5 trillion won ($3.26 billion) worth of pharmaceutical and biotechnologies, up 55 per cent from 2.9 trillion won (about $2.09 billion) for the same period last year, according to the data from the Korea Pharmaceutical and Bio-Pharma Manufacturers Association.

The number of export deals dropped to seven from 12 over the cited period, but the amount of each deal grew sharply, the association noted, adding that each of the three deals signed this month was worth over 500 billion won, reports Yonhap News Agency.

At the current rate, the country's annual total is expected to reach 8 trillion won, according to the association.

"This means the competitiveness of our country's pharmaceutical and biopharmaceutical technologies have significantly improved," an association official said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalGST reforms: A welcome decision but not a new wisdom, says K'taka CM

InternationalIsraeli President presses Pope Leo XIV to help free Hamas hostages

InternationalMauritius Prime Minister to visit India from September 9 to 16

NationalCommitted to resolving land-related issues: Telangana CM

AurangabadWomen thieves strike Handloom export, six mangalsutras snatched

Business Realted Stories

BusinessGST reforms to give our defense corridors a major boost: Gen Upendra Dwivedi

BusinessStudents should be drivers of innovation-led enterprises: Jitendra Singh

BusinessGST rate cut to boost MSMEs, push exports

BusinessTrump’s tariff war pits US geostrategic interests against Nobel pique, trade claims

BusinessGST 2.0 has brought in rationalisation of rates; revenues will go up: Ex-chairman of GSTN